Boiron SA
BOIR.PA- Latest Trade
- trading lower41.8EUR
- Change
- -0.05
- % Change
0.12%Negative
- Day Range
- 41.80 - 42.00
- 52-Week Range
- 32.60 - 48.00
As of May 25 2022. Values delayed up to 15 minutes
- Previous Close
- 41.85
- Open
- 42.00
- Volume
- 471.00
- 3 Month Average Trading Volume
- 0.21
- Shares Out (Mil)
- 17.51
- Market Cap
- 734.28
- Forward P/E
- 15.58
- Dividend Yield
- 2.27
Key Statistics
1.66666667 mean rating - 3 analysts
- P/E Excl. Extra Items (TTM)
- 25.68
- Price To Sales (TTM)
- 1.61
- Price To Book (Quarterly)
- 1.38
- Price To Cash Flow (Per Share TTM)
- 17.35
- Total Debt/Total Equity (Quarterly)
- 2.37
- Long Term Debt/Equity (Quarterly)
- 1.45
- Return On Investment (TTM)
- 4.69
- Return On Equity (TTM)
- 3.68
2021 (millions USD)
About Boiron SA
Company Information
Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
Address
2 avenue de l ouest LyonnaisRONTALON,
69510
France
Industry
Biotechnology & Drugs
Executive Leadership
- Thierry Boiron
- Chairman of the Board of Directors
- Valerie Lorentz-Poinsot
- Chief Executive Officer, General Manager, Director
- Jean-Christophe Michel Bayssat
- Deputy Chief Executive Officer (Deputy General Manager), Chief Pharmacist, Pharmaceutical Development Director
- Jacky Abecassis
- Non-Executive Director
- Laurence Boiron
- Non-Executive Director
- Michele Boiron
- Non-Executive Director
- Christine Boutin
- Non-Executive Director - Employees Representative
- Jean-Pierre Boyer
- Non-Executive Director
- Christine Boyer-Boiron
- Non-Executive Director
- Stephanie Chesnot
- Non-Executive Director
- Anabelle Flory-Boiron
- Non-Executive Director
- Bruno Grange
- Non-Executive Director
- Virginie Heurtaut
- Non-Executive Director
- Sylvain Mossaz
- Non-Executive Director - Employees Representative
- Gregory Walter
- Non-Executive Director, Representative of Shareholder Employees
- Michel Bouissou
- Non-Executive Independent Director
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,865.10 | -- |
| Copper | 780.45 | 0.10%Negative |
| Brent Crude Oil | 114.39 | 0.73%Positive |
| CBOT Soybeans | 1,677.25 | 0.93%Negative |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,943.74 | 0.06%Positive |
| Euro STOXX 50 | 3,670.78 | 0.64%Positive |
| FTSE 100 | 7,523.42 | 0.52%Positive |
| Nikkei 225 | 26,677.80 | 0.26%Negative |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes